Lilly’s Worst Nightmare: Compounders Directly Challenged Lilly’s Tirzepatide Patent In Court
We interrupt your regularly scheduled ADA updates to bring you this. A few weeks ago, something happened quietly that could send shockwaves through the entire obesity drug market.
Keep reading with a 7-day free trial
Subscribe to On The Pen to keep reading this post and get 7 days of free access to the full post archives.